Dried Blood Spot Collection Cards Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented by Card Type (Whatman 903, Ahlstrom 226, FTA, Others), By Application (New-born Screening (NBS), Infectious Disease Testing, Therapeutic Drug Monitoring, Forensics, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region

The infant mortality rate in the United States in 2019 was around 5.4 out of every 1,000 live births.

Use of Dried Blood Spot Collection Cards in Treatment/Detection of Diseases

Increasing application of dried blood spot collection cards for the treatment of newborn screening such as metabolic disorder, genetic disorder, maple syrup urine diseases, among others is expected to drive the growth of global dried blood spot collection cards market in the forecast period. Additionally, dried blood spot collection cards play an important role in the detection of HIV diseases. This in turn is leading to the widespread demanding of dried blood spot collection cards across the globe.

Benefits Associated with Dried Blood Spot Collection Cards

There are numerous benefits associated with dried blood spot collection cards which have increased their demand over the years. Dried Blood Spot Collection Cards are a simple and non-invasive method of collecting samples that can be used in screening and diagnosis of different diseases. Additionally, these cards are quite affordable and provide on time and effective diagnosis of different diseases. Besides, flexibility of use and preservation with dried blood spot collection cards has further increased their demand and is expected to support the market growth over the next few years.

Download Free Sample Report

Market Segmentation

Market Players

QIAGEN NV, PerkinElmer, Inc., Shimadzu Corporation, Pall Corporation, Eastern Business Forms, Inc., Archimed Life Science GmbH, Centogene N.V., F. Hoffmann-La Roche AG, Whatman Asia Pacific Pte. Ltd., DBS System SA